# Food noise on a GLP-1 · PepVault guides

Source: https://pepvault.app/guides/food-noise-on-a-glp-1

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Food noise on a GLP-1: what it is and what happens after stopping

Reviewed November 2026 21 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Food noise on a GLP-1: what the term means, how it is measured, what semaglutide and tirzepatide trials and users report, and what is known after stopping.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 21
- **Questions:** 8
- **Compounds:** 2

## The short answer

Food noise is the name people gave to constant, unwanted thoughts about food. No trial has measured it under that name yet, but semaglutide and tirzepatide trials show less hunger, fewer cravings and better control of eating than placebo, and users report it going quiet. After stopping, appetite tends to return and most lost weight comes back within a year; plan any stop with your prescriber.

Every number checked at its primary source · Nov 20, 2026 · [21 sources](https://pepvault.app/guides/food-noise-on-a-glp-1#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Randomised placebo-controlled trials in people on appetite, cravings and weight (semaglutide and tirzepatide), the FDA labels for Wegovy and Zepbound, surveys and interviews of users, one single-person brain recording, and rodent studies for the brain pathways; no trial has yet measured food noise by name, and appetite after stopping comes from interviews and one small uncontrolled study.

## What is food noise?

Food noise is a word that came from patients, not from a lab. As semaglutide spread, people taking it and their clinicians described a drop in what had come to be called food noise: less rumination and less preoccupation with food[1](https://pepvault.app/guides/food-noise-on-a-glp-1#source-1). Researchers have since tried to pin it down. One group defines it as persistent, intrusive thoughts about food that disrupt daily life and make healthy habits harder[2](https://pepvault.app/guides/food-noise-on-a-glp-1#source-2). Another adds that the thoughts feel unwanted or distressing, and that their intensity and intrusiveness set them apart from ordinary thinking about what to have for dinner[3](https://pepvault.app/guides/food-noise-on-a-glp-1#source-3).

The first group to review it put food noise at the far end of **food cue reactivity**, the body's and mind's response to the sight, smell or thought of food: a heightened or persistent version of that response, often leading to intrusive food thoughts and eating that works against you[1](https://pepvault.app/guides/food-noise-on-a-glp-1#source-1). It is not a diagnosis.

How many? In a nationally representative US survey of 1,000 adults in May 2026, 50.9% said they experience food noise at least occasionally and 18.0% often or always[4](https://pepvault.app/guides/food-noise-on-a-glp-1#source-4). Frequent food noise was more common in women, younger adults and people reporting loss of control over eating[4](https://pepvault.app/guides/food-noise-on-a-glp-1#source-4).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Food in the PepVault app has a food noise row: tap Quiet, Normal or Loud once a day, and it draws your last 14 days with a tick under each day you logged a shot. The doctor's report shows the average as appetite, from 1 (quiet) to 5 (loud).

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## How do researchers measure food noise?

Until 2025 there was no validated questionnaire, so the trials on GLP-1 drugs measured nearby things instead: hunger, fullness, cravings and how much people ate when given as much food as they wanted. Three tools matter for reading the evidence:

| Tool | What it asks | Where it has been used |
| --- | --- | --- |
| Food Noise Questionnaire (FNQ), 2025 | Five statements such as "I spend too much time thinking about food", each scored 0 to 4, for a total of 0 to 20. Tested in 396 adults; scores held steady over a week (r = 0.79)[2](https://pepvault.app/guides/food-noise-on-a-glp-1#source-2) | The INFORM survey of semaglutide users[13](https://pepvault.app/guides/food-noise-on-a-glp-1#source-13) |
| RAID-FN Inventory, 2025 | A second food noise questionnaire built on the formal definition above[3](https://pepvault.app/guides/food-noise-on-a-glp-1#source-3) | Its developers' own studies[3](https://pepvault.app/guides/food-noise-on-a-glp-1#source-3) |
| Control of Eating Questionnaire (CoEQ) | 19 questions on hunger, fullness, cravings and how well you can resist them; Blundell 2017 used a 16-question short form[10](https://pepvault.app/guides/food-noise-on-a-glp-1#source-10) [12](https://pepvault.app/guides/food-noise-on-a-glp-1#source-12) | The semaglutide appetite trials and STEP 5[10](https://pepvault.app/guides/food-noise-on-a-glp-1#source-10) [11](https://pepvault.app/guides/food-noise-on-a-glp-1#source-11) [12](https://pepvault.app/guides/food-noise-on-a-glp-1#source-12) |

The FNQ's developers include employees of WW International, the company behind WeightWatchers[2](https://pepvault.app/guides/food-noise-on-a-glp-1#source-2). The CoEQ's craving-control scores are the closest thing the drug trials have to a food noise measure.

## Why does a GLP-1 quiet food noise?

GLP-1 is a hormone the gut releases after a meal, and it is one of the body's own regulators of appetite and of how much is eaten[5](https://pepvault.app/guides/food-noise-on-a-glp-1#source-5). Semaglutide copies it; tirzepatide acts on the GLP-1 receptor and on a second one, GIP[5](https://pepvault.app/guides/food-noise-on-a-glp-1#source-5) [6](https://pepvault.app/guides/food-noise-on-a-glp-1#source-6). Both labels state that these receptors sit in brain areas that regulate appetite, and that the drop in calorie intake is likely mediated by appetite[5](https://pepvault.app/guides/food-noise-on-a-glp-1#source-5) [6](https://pepvault.app/guides/food-noise-on-a-glp-1#source-6).

In people, GLP-1 receptors have been found on neurons in the hypothalamus (the brain's appetite center), the brainstem and part of the cortex, in tissue from 22 human brains[7](https://pepvault.app/guides/food-noise-on-a-glp-1#source-7). In rats and mice, semaglutide reached the brainstem and hypothalamus and switched on neurons in 10 brain areas, including circuits that end a meal and circuits tied to reward[8](https://pepvault.app/guides/food-noise-on-a-glp-1#source-8). These are animal results; the human evidence comes from brain scans.

Those scans point at the reward side, the part of the brain that makes food feel urgent. In a randomized trial of 114 adults, three weeks of tirzepatide lowered brain activity when people looked at photos of high-fat, high-sugar food, in areas including the orbitofrontal cortex, which weighs how rewarding food is, and lowered their self-reported cravings and reactivity to food around them, compared with placebo[9](https://pepvault.app/guides/food-noise-on-a-glp-1#source-9). In 18 people with type 2 diabetes, 17 days of liraglutide, an older GLP-1 drug, dimmed the brain's response to pictures of highly desirable food[7](https://pepvault.app/guides/food-noise-on-a-glp-1#source-7).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## What did the trials find on hunger and cravings?

Every trial below was randomized, double-blind and placebo-controlled, in people with overweight or obesity. Each measured appetite directly, not only weight.

| Trial | Who and how long | What changed against placebo |
| --- | --- | --- |
| Blundell 2017, semaglutide | 30 adults with obesity, 12 weeks at up to 1.0 mg, crossover | 24% less food eaten across a day of all-you-can-eat meals; less hunger and fewer cravings; better control of eating; less preference for high-fat food[10](https://pepvault.app/guides/food-noise-on-a-glp-1#source-10) |
| Friedrichsen 2021, semaglutide | 72 adults with obesity, 20 weeks | 35% less eaten at an all-you-can-eat lunch; less hunger, more fullness; fewer and weaker cravings and better control of eating on the CoEQ[11](https://pepvault.app/guides/food-noise-on-a-glp-1#source-11) |
| STEP 5, semaglutide | 174 adults in the CoEQ subgroup, 2 years | Better craving control and fewer savoury cravings at weeks 20, 52 and 104; hunger and fullness differed only at week 20[12](https://pepvault.app/guides/food-noise-on-a-glp-1#source-12) |
| Martin 2025, tirzepatide | 114 adults, 6 weeks | About 525 kcal less eaten at an all-you-can-eat lunch at week 3; less appetite, fewer cravings, less pull from food around them[9](https://pepvault.app/guides/food-noise-on-a-glp-1#source-9) |

Each bar is a placebo-controlled trial; only STEP 5 followed cravings for two years.

The pattern is consistent: the drugs turn down cravings and the urge to keep eating, not just stomach hunger. In STEP 5, the more a person's cravings improved, the more weight they had lost by week 104[12](https://pepvault.app/guides/food-noise-on-a-glp-1#source-12).

## What do people on a GLP-1 report?

These are reports, not trials. In the INFORM survey, 550 US adults on semaglutide for weight rated their food noise before starting, from memory, and now: the median FNQ score fell from 13 to 6 out of 20, and agreement with food noise statements fell from 47-63% to 15-20%[13](https://pepvault.app/guides/food-noise-on-a-glp-1#source-13). The survey was run for Novo Nordisk, semaglutide's maker, and relied on recall[13](https://pepvault.app/guides/food-noise-on-a-glp-1#source-13).

In 30 video interviews led by Stanford researchers, the first theme they listed was less food noise, psychological hunger or appetite, along with the view that the drug helps lifestyle change rather than replacing it[14](https://pepvault.app/guides/food-noise-on-a-glp-1#source-14). In 31 interviews with people on obesity medications, those early in their weight loss described reduced food noise, early fullness and smaller portions; smaller portions lasted into the stable phase[15](https://pepvault.app/guides/food-noise-on-a-glp-1#source-15).

**Commonly reported:** the background chatter about the next meal or snack fading within days to weeks of starting, with meals ending sooner and portions shrinking without effort. Some people describe it as the first time in years they did not think about food between meals.

## Can food noise come back while you are still taking it?

It can change over time. In STEP 5, semaglutide's effect on hunger and fullness ratings showed against placebo only at week 20, while the effect on craving control held through two years[12](https://pepvault.app/guides/food-noise-on-a-glp-1#source-12). In the interviews of 31 people, some in the stable phase described a sense that the drug was working less, and some considered switching[15](https://pepvault.app/guides/food-noise-on-a-glp-1#source-15).

One rare case shows it inside the brain. A woman with type 2 diabetes and severe loss-of-control eating had electrodes placed in the nucleus accumbens, a reward hub, as part of a trial[16](https://pepvault.app/guides/food-noise-on-a-glp-1#source-16). On tirzepatide, episodes of severe food preoccupation became rare in months two to four after surgery; in months five to seven it broke through again despite the maximum dose, and a low-frequency brain signal rose before it did[16](https://pepvault.app/guides/food-noise-on-a-glp-1#source-16). That is one person, so it shows what can happen, not how often.

## What happens to food noise after stopping a GLP-1?

No study has measured food noise by name after stopping (our PubMed search, November 20, 2026), but two have asked about appetite. In exit interviews from SURMOUNT-4, 36 of the 86 people had been switched to placebo without knowing it; of the 28 who talked about appetite in that phase, 24 said it got worse, such as wanting more to eat and willpower no longer coming easily[20](https://pepvault.app/guides/food-noise-on-a-glp-1#source-20). In 28 women who stopped semaglutide after 36 weeks, 78.5% reported their appetite rebounding within 12 weeks[21](https://pepvault.app/guides/food-noise-on-a-glp-1#source-21). The interviews were run for Eli Lilly, tirzepatide's maker, and the second study had no placebo group, so both show the direction, not the size.

Look at the empty lane: weight was tracked after stopping, appetite was not.

Weight is better measured. A year after semaglutide and the lifestyle program ended in the STEP 1 extension, people had regained two-thirds of the weight they had lost[17](https://pepvault.app/guides/food-noise-on-a-glp-1#source-17). In SURMOUNT-4, people switched from tirzepatide to placebo gained 14.0% in weight over the next year, while those who stayed on it lost another 5.5%[18](https://pepvault.app/guides/food-noise-on-a-glp-1#source-18).

The drug leaves slowly. Semaglutide has a half-life of about a week and stays in the blood for about 5 to 7 weeks after the last injection; tirzepatide's half-life is about 5 days[5](https://pepvault.app/guides/food-noise-on-a-glp-1#source-5) [6](https://pepvault.app/guides/food-noise-on-a-glp-1#source-6). So appetite would return over weeks, not days, though no placebo-controlled trial has tracked it after the last dose.

In the 2026 US survey, the 53 people who had stopped a GLP-1 within the past year reported frequent food noise more often than people who never used one (26.8% against 16.3%), and so did current users[4](https://pepvault.app/guides/food-noise-on-a-glp-1#source-4). The authors think this most likely reflects who starts the drugs, people with obesity or insulin resistance, which go with stronger reactions to food cues, rather than an effect of the drugs[4](https://pepvault.app/guides/food-noise-on-a-glp-1#source-4). The often repeated claim that food noise returns louder than before has no study behind it yet. The guide Stopping a GLP-1: what happens to your weight covers the regain in full.

## How can you track your own food noise?

A daily rating turns a feeling into a record you and your prescriber can read, during treatment, around a dose change and after any stop.

1. Pick one time each day, such as the evening, and rate the day's food noise as quiet, normal or loud.
2. Mark the days you take your injection, so you can see how the noise runs across the week.
3. Start a few days before a planned change (a new dose, a switch or a stop), so you have a baseline to compare against.
4. Once a week, answer the five statements of the Food Noise Questionnaire if you want a 0-20 score that matches the research[2](https://pepvault.app/guides/food-noise-on-a-glp-1#source-2).
5. Bring the record to your next appointment, along with your weight.

Read the dots against the ticks: the pattern across your week is the record your prescriber can use.

<!--promo-->

Food in the PepVault app has a food noise row: tap Quiet, Normal or Loud once a day, and it draws your last 14 days with a tick under each day you logged a shot. The doctor's report shows the average as appetite, from 1 (quiet) to 5 (loud). [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-food-noise-on-a-glp-1-inline&mt=8)

<!--/promo-->

**When to get help** If thoughts about food feel out of your control, or you notice binge eating or making up for eating by vomiting, laxatives or fasting, tell your prescriber; an eating-disorder service can help too[19](https://pepvault.app/guides/food-noise-on-a-glp-1#source-19).

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Hayashi D et al. What is food noise? A conceptual model of food cue reactivity. Nutrients. 2023. [PubMed 38004203](https://pubmed.ncbi.nlm.nih.gov/38004203/)
2. Diktas HE et al. Development and validation of the Food Noise Questionnaire. Obesity (Silver Spring). 2025. [PubMed 39828656](https://pubmed.ncbi.nlm.nih.gov/39828656/)
3. Dhurandhar EJ et al. Food noise: definition, measurement, and future research directions. Nutr Diabetes. 2025. [PubMed 40628707](https://pubmed.ncbi.nlm.nih.gov/40628707/)
4. Hayashi D, Masterson TD. Prevalence and correlates of perceived food noise among U.S. adults in a nationally representative sample. Obes Sci Pract. 2026. [PubMed 42801078](https://pubmed.ncbi.nlm.nih.gov/42801078/)
5. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information. DailyMed, revised June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
6. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information. DailyMed, revised August 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
7. Farr OM et al. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes. Diabetologia. 2016. [PubMed 26831302](https://pubmed.ncbi.nlm.nih.gov/26831302/)
8. Gabery S et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight. 2020. [PubMed 32213703](https://pubmed.ncbi.nlm.nih.gov/32213703/)
9. Martin CK et al. Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial. Nat Med. 2025. [PubMed 40555748](https://pubmed.ncbi.nlm.nih.gov/40555748/)
10. Blundell J et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017. [PubMed 28266779](https://pubmed.ncbi.nlm.nih.gov/28266779/)
11. Friedrichsen M et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021. [PubMed 33269530](https://pubmed.ncbi.nlm.nih.gov/33269530/)
12. Wharton S et al. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring). 2023. [PubMed 36655300](https://pubmed.ncbi.nlm.nih.gov/36655300/)
13. Arnaut T et al. Retrospective assessment of food noise changes after initiation of injectable semaglutide for weight management in the USA: the INFORM survey. Adv Ther. 2026. [PubMed 42217114](https://pubmed.ncbi.nlm.nih.gov/42217114/)
14. de Vere Hunt I et al. Patient experiences with GLP-1 receptor agonists. JAMA Netw Open. 2026. [PubMed 42247231](https://pubmed.ncbi.nlm.nih.gov/42247231/)
15. Chong MC et al. Changes in eating behaviour during treatment with obesity medications. Clin Obes. 2026. [PubMed 41420306](https://pubmed.ncbi.nlm.nih.gov/41420306/)
16. Choi W et al. Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. Nat Med. 2025. [PubMed 41249493](https://pubmed.ncbi.nlm.nih.gov/41249493/)
17. Wilding JPH et al.; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022. [PubMed 35441470](https://pubmed.ncbi.nlm.nih.gov/35441470/)
18. Aronne LJ et al.; SURMOUNT-4 Investigators. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024. [PubMed 38078870](https://pubmed.ncbi.nlm.nih.gov/38078870/)
19. Allison KC et al. Disordered eating attitudes and behaviors in individuals with BMI > 27 kg/m2 treated by semaglutide: a 60-week randomized placebo-controlled trial. Int J Eat Disord. 2026. [PubMed 43035836](https://pubmed.ncbi.nlm.nih.gov/43035836/)
20. Carmichael C et al. Patient experience of treatment with tirzepatide for weight management: exit interviews from SURMOUNT-4. Patient. 2025. [PubMed 39987302](https://pubmed.ncbi.nlm.nih.gov/39987302/)
21. Wang N et al. Post-semaglutide weight regain in females with obesity: associations with gut microbiota, bile acid metabolism, and central nervous system. Diabetes Obes Metab. 2026. [PubMed 41705640](https://pubmed.ncbi.nlm.nih.gov/41705640/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)

GLP-1s in menopause: tirzepatide weight loss by menopause stage, semaglutide with hormone therapy, the pill, bone and fractures, and the hot-flash trials.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)

  What to expect on retatrutide week by week: the trial dose steps, when appetite drops, weight loss at weeks 24, 48 and 80, and how side effects settle.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
